Carl Zeiss Meditec AG (ETR:AFX)

Market Cap	3.50B
Revenue (ttm)	2.23B
Net Income (ttm)	141.21M
Shares Out	87.54M
EPS (ttm)	1.61
PE Ratio	24.80
Forward PE	20.20
Dividend	0.55 (1.38%)
Ex-Dividend Date	Mar 27, 2026

Volume	7,489
Average Volume	219,495
Open	39.78
Previous Close	40.00
Day's Range	39.64 - 40.30
52-Week Range	38.62 - 71.65
Beta	1.55
RSI	36.07
Earnings Date	Dec 11, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and p...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1846
• Employees: 5,784
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: AFX

Financial Performance

In 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.